𝔖 Bobbio Scriptorium

✦ LIBER ✦

New protein comprising at least one hepatitis A virus epitope; capsid protein expression in vaccinia virus vector for use as recombinant vaccine

Book ID: 119151156
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 129 KB
Volume: 10
Category: Article
ISSN: 0264-410X
DOI: 10.1016/0264-410x(92)90034-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New hybrid protein containing epitopes o

New hybrid protein containing epitopes of several antigens including a Plasmodium falciparum antigen, sequence cloning in recombinant vaccinia virus vector for use as vaccine

📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Immediate-early herpes simplex virus-2 p

Immediate-early herpes simplex virus-2 protein ICP27; gene cloning and expression using a bacterium host, vaccinia virus vector or herpes simplex virus light particle, for use as a recombinant vaccine

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Vaccine against hanta virus infections;

Vaccine against hanta virus infections; Hantaan virus nucleocapsid protein-N, glycoprotein G1 and glycoprotein-G2 gene expression in vaccinia virus vector for use as a recombinant vaccine : U.S. Army USA 5614 193; 25 March 1997

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Fusion protein of Plasmodium circumsporo

Fusion protein of Plasmodium circumsporozoite protein and hepatitis B virus surface antigen; expression in Saccharomyces cerevisiae for use as a recombinant vaccine for Plasmodium infection prevention

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 84 KB

New mosaic hepatitis E virus polypeptide

New mosaic hepatitis E virus polypeptides; recombinant protein production by vector expression for use as a recombinant vaccine : U.S. Dep. Health Hum. Serv. Nat. Inst. Health Bethesda World 9521 858; 17 August 1995

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 173 KB

New vaccines against hepatitis C virus;

New vaccines against hepatitis C virus; recombinant envelope protein production by vector expression in e.g. Escherichia coli, for application as a recombinant vaccine : SK Beecham Biol. World 9701 640; 16 January 1997

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 385 KB